Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
Hosted on MSN48m
AMD Stock Tumbles On Analyst’s Double Downgrade Flagging AI GPU Weakness: Retail Sentiment Holds StrongAdvanced Micro Devices Inc. (AMD) stock tumbled more than 3% in pre-market trading on Wednesday after HSBC analysts double ...
Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback